GL1X · GenesisL1 explorer

Research workbench

Delta (B.1.617.2) SARS-cov-2 variant spike protein (S-gsas-delta) in the 3-rbd-down conformation; consensus state D1

Analyse Delta (B.1.617.2) SARS-cov-2 variant spike protein (S-gsas-delta) in the… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7TOU
Type
protein
Length
3,050 residues
Chains
3
Method
electron microscopy
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Spike glycoprotein
UniProt
P0DTC2
Ligands
NAG
Pockets
20 · best druggability 0.86

Structure

electron microscopy · 2 distinct chains · 23% helix, 32% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BSpike glycoproteinprotein101423% helix, 32% strandP0DTC2
CSpike glycoproteinprotein102223% helix, 33% strandP0DTC2

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 61 copies · chains A, C, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

20 pockets found on a 1 Å grid, 20 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19430.860.87117empty
27490.850.8874empty
311910.830.84140empty
45300.810.8861empty
59730.790.8196empty

Interfaces

3 interfaces between chains.

  • B–C · 5243 Ų buried · 39 hydrogen bonds · protein-protein
  • A–B · 5013 Ų buried · 40 hydrogen bonds · protein-protein
  • A–C · 4732 Ų buried · 40 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 47 glycan, 39 disulfide (N-glycosylation, disulfide).

Compared structures

  • 7TOU · Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 3-RBD-down… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.